Evidence map›Paper›PMID 39307288›Full record

ArticleThe Journal of allergy and clinical immunology2025

Clinical and molecular analysis of longitudinal rhinitis phenotypes in an urban birth cohort.

Sima K Ramratnam, Molly Johnson, Cynthia M Visness, Agustin Calatroni, Mathew C Altman, Tomasz Janczyk, Kathryn E McCauley, Claire Schachtschneider, Kei E Fujimura, Douglas W Fadrosh and 11 more

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sima K RamratnamDepartment of Pediatrics, University of Wisconsin-Madison, Madison, Wis. Electronic address: sramratnam@wisc.edu.
Molly JohnsonRho Inc, Federal Research Operations, Durham, NC.
Cynthia M VisnessRho Inc, Federal Research Operations, Durham, NC.
Agustin CalatroniRho Inc, Federal Research Operations, Durham, NC.
Mathew C AltmanBenaroya Research Institute Systems Immunology Division, Seattle, Wash; University of Washington Department of Medicine, Seattle, Wash.
Tomasz JanczykBenaroya Research Institute Systems Immunology Division, Seattle, Wash; University of Washington Department of Medicine, Seattle, Wash.
Kathryn E McCauleyDepartment of Medicine, University of California San Francisco, San Francisco, Calif.
Claire SchachtschneiderDepartment of Medicine, University of California San Francisco, San Francisco, Calif.
Kei E FujimuraDepartment of Medicine, University of California San Francisco, San Francisco, Calif.
Douglas W FadroshDepartment of Medicine, University of California San Francisco, San Francisco, Calif.
Susan V LynchDepartment of Medicine, University of California San Francisco, San Francisco, Calif.
Leonard B BacharierDepartment of Pediatrics, Monroe Carrel Jr Children's Hospital at Vanderbilt, Nashville, Tenn.
George T O'ConnorDepartment of Medicine, Boston University School of Medicine, Boston, Mass.
Megan T SandelDepartment of Medicine, Boston University School of Medicine, Boston, Mass.
Meyer KattanDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY.
Robert A WoodDepartment of Pediatrics, Johns Hopkins University Medical Center, Baltimore, Md.
Peter J GergenNational Institute of Allergy and Infectious Diseases, Rockville, Md.
Daniel J JacksonDepartment of Pediatrics, University of Wisconsin-Madison, Madison, Wis.
Alkis TogiasNational Institute of Allergy and Infectious Diseases, Rockville, Md.
James E GernDepartment of Pediatrics, University of Wisconsin-Madison, Madison, Wis.
Childhood Asthma in Urban Settings (CAUSE) Network

Funding

Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Inner City Asthma consortium 3 (ICAC3)UM1AI114271 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E., JACKSON, DANIEL J · 2014 to 2021
$79.4M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Childhood Asthma in Urban Settings Leadership Center Administrative Supplement for URECA Yr4UM1AI160040 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI James E. Gern, DANIEL J JACKSON · 2021 to 2026
$41.1M
RhoFED AA-SCCCU01AI178772 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI Gloria David, Cynthia M Visness · 2023 to 2026
$37.2M
NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1 TR001430NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002345NIAID NIH HHS U01 AI178772NIAID NIH HHS UM1 AI114271NIAID NIH HHS UM1 AI160040NIAID NIH HHS UM2 AI117870
6 · The paper itself

Abstract

backgroundChronic rhinitis symptoms cause significant health burden among children and can have a heterogeneous presentation. Defining phenotypes of childhood chronic rhinitis and associated pathobiology may lead to prevention or improved treatments.

objectivesWe sought to identify longitudinal patterns of rhinitis symptoms in childhood and determine their associations with early life risk factors, allergic comorbidities, and nasal epithelial cell gene expression.

methodsChronic rhinitis symptoms were evaluated from ages 1 through 11 years in 485 urban children at high risk for allergic disease in the URECA (Urban Environment and Childhood Asthma) birth cohort. We identified longitudinal rhinitis phenotypes and their relationships to early life exposures, atopic comorbidities, and patterns of nasal epithelial gene expression at age 11 years.

resultsChronic rhinitis symptoms started early in many children and were a risk factor for developing aeroallergen sensitization. We identified 4 longitudinal rhinitis phenotypes: low/minimal, persistent, persistent decreasing, and late increasing. Persistent rhinitis was most closely linked to allergic sensitization and asthma. Risk factors for persistent rhinitis included frequent colds (P < .001), antibiotic use (P < .001), and reduced exposure to common indoor aeroallergens (P = .003). Compared to low/minimal rhinitis phenotype, the other rhinitis phenotypes were associated with increased expression of canonical type 2 genes and decreased expression of immune response genes.

conclusionsIn urban children, rhinitis symptoms often precede aeroallergen sensitization. Rhinitis phenotypes based on symptoms had distinct risk factors and nasal transcriptome. These results suggest that focusing on early life risk factors and distinct immune mechanisms may be a target to preventing chronic rhinitis in childhood.

Indexed as

RhinitisAllergensAsthmaBirth CohortChildChild, PreschoolChronic DiseaseCohort StudiesFemaleHumansInfantLongitudinal StudiesMaleNasal MucosaPhenotypeRisk FactorsAllergensallergic sensitizationChronic rhinitisendotypesenvironmental exposureshay feverphenotypesseasonal rhinitistranscriptomics

Identifiers

PMID39307288
PMCPMC11805661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.